Skip to main content
Transforming Care and Inspiring Hope for all children...

Neonatal inflammation and its association with asthma and obesity in late childhood among individuals born extremely preterm. 

December 1, 2024
Emmanuel C, Oran A, Jensen ET, Fichorova RN, Gower WA, Perrin EM, Sanderson K, South AM, Gogcu S, Shenberger J, Singh R, Makker K, Thompson AL, Santos H, Fry RC, O'Shea TM; ELGAN-ECHO Study Investigators. Pediatr Res. 2024 Dec;96(7):1749-1758. doi: 10.1038/s41390-024-03325-x. PMID: 38914762.

Understanding Trends in Pediatric Drowning Injuries in North Carolina.

December 1, 2024
Olcese M, Waller AE. South Med J. 2024 Dec;117(12):690-695. doi: 10.14423/SMJ. 0000000000001763. PMID: 39622517.

Identifying and supporting vaccine champions in pediatric primary care: a qualitative interview study.

November 25, 2024
Kong WY, Heisler-MacKinnon J, Oh NL, McKeithen MC, Stalford SR, Brennan MB, Shea CM, Liu A, Gottfredson O'Shea N, Ozawa S, Brewer NT, Gilkey MB. Transl Behav Med. 2024 Nov 25;14(12):722-731. doi: 10.1093/tbm/ibae054. PMID: 39402839.

Unique T cell signatures associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort.

November 8, 2024
Yount KS, Chen CJ, Kollipara A, Liu C, Mokashi NV, Zheng X, Bagwell CB, Poston TB, Wiesenfeld HC, Hillier SL, O'Connell CM, Stanley N, Darville T. bioRxiv [Preprint]. 2024 Nov 8:2023.08.02.551709. doi: 10.1101/2023.08.02.551709. PMID: 37577476.

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection.

November 1, 2024
Pickles RJ, Chen G, Randell SH. J Clin Invest. Nov. 12024;134:e185689. PMCID: PMC11527439. DOI: 10.1172/JCI185689. PMID: 39484717

Airway inflammation enhances the effectiveness of elexacaftor-tezacaftor-ivacaftor therapy for cystic fibrosis and CFTR N1303K mutation.

November 1, 2024
Gentzsch M, Esther CR Jr, Ribeiro CMP. Lancet Respir Med. Nov 2024;12:e67.DOI: 10.1016/S2213-2600(24)00305-9. PMID: 39395437.

EMC3 regulates trafficking and pulmonary toxicity of the SFTPCI73T mutation associated with interstitial lung disease.

October 15, 2024
Tang X, Wei W, Sun Y, Weaver TE, Nakayasu ES, Clair G, Snowball JM, Na CL, Apsley KS, Martin EP, Kotton DN, Alysandratos KD, Huo J, Molkentin JD, Gower WA, Lin X, Whitsett JA. J Clin Invest. 2024 Oct 15;134(23):e173861. doi: 10.1172/JCI173861. PMID: 39405113.

Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II.

September 1, 2024
Muenzer J, Burton BK, Harmatz P, Gutiérrez-Solana LG, Ruiz-Garcia M, Jones SA, Guffon N, Inbar-Feigenberg M, Bratkovic D, Rust S, Hale M, Wu Y, Yee KS, Whiteman DAH, Alexanderian D.J Inherit Metab Dis. 2024 Sep 9. doi: 10.1002/jimd.12790. Online ahead of print. PMID: 39252529

Genotype-phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey. 

September 1, 2024
Muenzer J, Amartino H, Burton BK, Scarpa M, Tylki-Szymańska A, Audi J, Botha J, Fertek D, Merberg D, Natarajan M, Whiteman DAH, Giugliani R. Mol Genet Metab. 2024 Sep-Oct;143(1-2):108576. doi: 10.1016/j.ymgme.2024.108576. Epub 2024 Sep 10. PMID: 39303318.

Integrating education for clinical practice change.

August 29, 2024
Chawla EM, Schuler CL, Barnhardt EW, Herbst LA, Sarkissian A, McNeal-Trice K, Newmeyer A, Perry M, Poynter SE, Lannon C. Clin Teach. 2024 Aug;21(4):e13753. doi: 10.1111/tct.13753. Epub 2024 Feb 29.PMID: 38419551.